When Infection Drives Autoimmunity: Mycobacterium abscessus -Associated MPO-ANCA Glomerulonephritis-A Cytotoxic-Sparing Treatment Approach.
文献摘要
Background Nontuberculous mycobacterial (NTM) infections are increasingly recognized as triggers of antineutrophil cytoplasmic antibody (ANCA) positivity and secondary ANCA-associated vasculitis. Differentiating infection-associated ANCA disease from primary AAV is critical because management and outcomes differ. This case describes an uncommon organism triggering MPO-ANCA glomerulonephritis and a management approach that avoided cytotoxic agents. Case presentation A 57-year-old woman with chronic pulmonary disease presented with acute kidney injury, glomerular-pattern (dysmorphic) microscopic hematuria, proteinuria, and MPO-ANCA positivity. Kidney biopsy demonstrated pauci-immune necrotizing and crescentic glomerulonephritis with marked chronicity (∼70% globally sclerosed glomeruli). Evaluation revealed pulmonary infection with multidrug-resistant Mycobacterium abscessus complex. Given active infection, cyclophosphamide and rituximab were withheld. The patient received pulse intravenous methylprednisolone followed by oral prednisone with targeted antimicrobial therapy. Outcome Over approximately 6 months of follow-up, serum creatinine improved from a peak of 3.9 mg/dL to 2.2 mg/dL and subsequently to 1.9 mg/dL, ESR and CRP normalized from peaks of 102 mm/h and 68 mg/L, hematuria resolved, and proteinuria decreased. Quantitative MPO-ANCA, elevated at presentation, showed a progressive downtrend but remained detectable at last follow-up. The renal course is best characterized as stabilization with partial improvement on a background of advanced chronic damage. Conclusion This case highlights M. abscessus as a rare trigger of infection-associated MPO-ANCA glomerulonephritis and demonstrates that antimicrobial therapy combined with corticosteroids, without cytotoxic agents, can achieve renal stabilization and partial improvement. A downtrending MPO-ANCA titer, rather than a static one, is the serologic pattern most consistent with a resolving infection-associated process. Recognition of infection-driven ANCA disease is essential to avoid potentially harmful cytotoxic therapy during active infection.